- Home
- CDNA vs GAM Comparison
CDNA vs GAM Comparison
Compare CDNA & GAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDNA
- GAM
- Stock Information
- Founded
- CDNA 1998
- GAM 1927
- Country
- CDNA United States
- GAM United States
- Employees
- CDNA N/A
- GAM N/A
- Industry
- CDNA Medical Specialities
- GAM Investment Managers
- Sector
- CDNA Health Care
- GAM Finance
- Exchange
- CDNA Nasdaq
- GAM Nasdaq
- Market Cap
- CDNA 1.0B
- GAM 1.3B
- IPO Year
- CDNA 2014
- GAM N/A
- Fundamental
- Price
- CDNA $19.21
- GAM $56.04
- Analyst Decision
- CDNA Buy
- GAM
- Analyst Count
- CDNA 6
- GAM 0
- Target Price
- CDNA $30.33
- GAM N/A
- AVG Volume (30 Days)
- CDNA 989.3K
- GAM 20.1K
- Earning Date
- CDNA 07-30-2025
- GAM 01-01-0001
- Dividend Yield
- CDNA N/A
- GAM 5.74%
- EPS Growth
- CDNA N/A
- GAM N/A
- EPS
- CDNA 1.07
- GAM 11.67
- Revenue
- CDNA $346,421,000.00
- GAM N/A
- Revenue This Year
- CDNA $13.31
- GAM N/A
- Revenue Next Year
- CDNA $15.46
- GAM N/A
- P/E Ratio
- CDNA $17.90
- GAM $3.95
- Revenue Growth
- CDNA 25.92
- GAM N/A
- 52 Week Low
- CDNA $14.09
- GAM $37.32
- 52 Week High
- CDNA $34.84
- GAM $46.48
- Technical
- Relative Strength Index (RSI)
- CDNA 57.48
- GAM 67.43
- Support Level
- CDNA $18.64
- GAM $53.78
- Resistance Level
- CDNA $19.44
- GAM $55.31
- Average True Range (ATR)
- CDNA 0.75
- GAM 0.54
- MACD
- CDNA -0.05
- GAM -0.04
- Stochastic Oscillator
- CDNA 46.86
- GAM 93.59
About CDNA CareDx Inc.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.
About GAM General American Investors Inc.
General American Investors Co Inc is a closed-end, diversified management investment company. The primary investment objective of the company is long-term capital appreciation through investment in companies with above-average growth potential. It focuses on equity securities with growth potential at reasonable valuations.